486 related articles for article (PubMed ID: 37265797)
21. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
22. Succinate metabolism and its regulation of host-microbe interactions.
Wei YH; Ma X; Zhao JC; Wang XQ; Gao CQ
Gut Microbes; 2023; 15(1):2190300. PubMed ID: 36946592
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin.
Lopetuso LR; Petito V; Scaldaferri F; Gasbarrini A
Mini Rev Med Chem; 2015; 16(3):179-85. PubMed ID: 26643042
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges.
Zhang W; An Y; Qin X; Wu X; Wang X; Hou H; Song X; Liu T; Wang B; Huang X; Cao H
Front Oncol; 2021; 11():739648. PubMed ID: 34733783
[TBL] [Abstract][Full Text] [Related]
25. Impact of intestinal dysbiosis on breast cancer metastasis and progression.
Zhang J; Xie Q; Huo X; Liu Z; Da M; Yuan M; Zhao Y; Shen G
Front Oncol; 2022; 12():1037831. PubMed ID: 36419880
[TBL] [Abstract][Full Text] [Related]
26. Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure.
Jia Q; Li H; Zhou H; Zhang X; Zhang A; Xie Y; Li Y; Lv S; Zhang J
Cardiovasc Ther; 2019; 2019():5164298. PubMed ID: 31819762
[TBL] [Abstract][Full Text] [Related]
27. Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder.
Chen CY; Wang YF; Lei L; Zhang Y
Life Sci; 2024 Jun; 351():122815. PubMed ID: 38866215
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
Strati F; Pujolassos M; Burrello C; Giuffrè MR; Lattanzi G; Caprioli F; Troisi J; Facciotti F
Microbiome; 2021 Feb; 9(1):39. PubMed ID: 33549144
[TBL] [Abstract][Full Text] [Related]
29. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
[TBL] [Abstract][Full Text] [Related]
30. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
Wang M; Zhang L; Chang W; Zhang Y
Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
[TBL] [Abstract][Full Text] [Related]
31. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
[TBL] [Abstract][Full Text] [Related]
32. The progress on the relationship between gut microbiota and immune checkpoint blockade in tumors.
Jiang H; Ye Y; Wang M; Sun X; Sun T; Chen Y; Li P; Zhang M; Wang T
Biotechnol Genet Eng Rev; 2023 May; ():1-20. PubMed ID: 37191003
[TBL] [Abstract][Full Text] [Related]
33. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection.
Sun X; Pan CQ; Xing H
Hepatol Int; 2021 Oct; 15(5):1053-1067. PubMed ID: 34596865
[TBL] [Abstract][Full Text] [Related]
34. Emerging Relationship between the Gut Microbiome and Prostate Cancer.
Matsushita M; Fujita K; Hatano K; De Velasco MA; Tsujimura A; Uemura H; Nonomura N
World J Mens Health; 2023 Oct; 41(4):759-768. PubMed ID: 36876743
[TBL] [Abstract][Full Text] [Related]
35. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
36. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
37. What We Know So Far about the Metabolite-Mediated Microbiota-Intestinal Immunity Dialogue and How to Hear the Sound of This Crosstalk.
Caffaratti C; Plazy C; Mery G; Tidjani AR; Fiorini F; Thiroux S; Toussaint B; Hannani D; Le Gouellec A
Metabolites; 2021 Jun; 11(6):. PubMed ID: 34205653
[TBL] [Abstract][Full Text] [Related]
38. Microbiome-Metabolomics Analysis of the Impacts of
Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
[TBL] [Abstract][Full Text] [Related]
39. Plant-Derived Bioactive Compounds and Potential Health Benefits: Involvement of the Gut Microbiota and Its Metabolic Activity.
Chen X; Pan S; Li F; Xu X; Xing H
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551299
[TBL] [Abstract][Full Text] [Related]
40. The relationship among avian influenza, gut microbiota and chicken immunity: an updated overview.
Abd El-Hack ME; El-Saadony MT; Alqhtani AH; Swelum AA; Salem HM; Elbestawy AR; Noreldin AE; Babalghith AO; Khafaga AF; Hassan MI; El-Tarabily KA
Poult Sci; 2022 Sep; 101(9):102021. PubMed ID: 35939896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
